Particularly, the proportions of SSc patients suffering from SSc-related vascular complications such as digital ulcerations, Raynaud’s syndrome, or pulmonary arterial hypertension were comparable among both CRP− groups, as were the proportions of vasodilatory drug users (p > 0.05). The gene discussed is CRP; the disease is Raynaud disease.